ArticleBioengineered2022

Suppression of the transforming growth factor-β signaling pathway produces a synergistic effect of combination therapy with programmed death receptor 1 blockade and radiofrequency ablation against hepatic carcinoma in mice.

Xiaoxiang Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.